The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery

NCT03311581 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease
Hemodialysis Complication

Interventions

DRUG: Propofol
DEVICE: Sevoflurane

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital